Skip to main content
Fig. 2 | BMC Anesthesiology

Fig. 2

From: Increased circulating microRNA-122 is associated with mortality and acute liver injury in the acute respiratory distress syndrome

Fig. 2

Thirty-day survival in patients with the acute respiratory distress syndrome (ARDS) stratified for patients with and without acute liver injury (ALI), defined as a total serum bilirubin concentration ≥ 3 mg/dl, an ALT activity ≥350 U/I, and an INR ≤2.0. Kaplan-Meier estimates were used to calculate probabilities of 30-day survival. Thirty-day survival was 77% in patients not suffering from acute liver injury but only 19% in ARDS patients with an ALI (p < 0.001)

Back to article page

BMC Anesthesiology

ISSN: 1471-2253

Contact us